Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine neuroprotection in supratentorial tumor resection
ChiCTR2300073509Phase 4Not yet recruiting
- Sponsor
- 904th Hospital of the Joint Logistic Support Force
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Supratentorial neoplasm (STBT) (2 arms), sponsored by 904th Hospital of the Joint Logistic Support Force. Primary endpoints: S-100β, neuron-specific enolase and 1 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Supratentorial neoplasm (STBT)
Beyond the preview
Go deeper on ChiCTR2300073509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073509.